Prostate cancer
Clinical research activity is centered on prostate cancer, with interest in treatment-related quality of life and supportive care during androgen deprivation therapy and radiation therapy.
- Sexual dysfunction
- Hormone therapy adverse effects
- Radiation therapy–associated supportive care
The sponsor’s trial portfolio reflects a focus on managing functional and symptom-related outcomes in men receiving treatment for prostate cancer.
Endocrine and hormonal effects
Research interest includes the hormonal consequences of androgen deprivation therapy, with attention to restoring balance in patients experiencing treatment-related changes in sexual function and overall well-being.
- Estrogen-based supportive treatment
- Hormone-related symptom management
- Treatment-induced quality-of-life changes
These topics place emphasis on the endocrine dimension of care in men undergoing therapy for prostate cancer.
Exercise and rehabilitation
The sponsor also funds work related to exercise as a supportive intervention for patients coping with the adverse effects of cancer treatment, particularly during prolonged hormonal suppression.
- Physical activity support
- Rehabilitation in oncology
- Functional recovery
This area links movement-based care with symptom relief and maintenance of daily functioning during prostate cancer treatment.
Men’s health and supportive oncology
Clinical interest extends to men’s health concerns arising during cancer treatment, especially symptoms affecting intimacy, physical comfort, and treatment tolerance.
- Supportive oncology
- Patient-reported outcomes
- Symptom burden during cancer care
Research in this area is directed toward the lived experience of patients receiving active treatment for prostate cancer.
